Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-02

Clinical Trial Update: Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study [NA]

View source ↗

Summary

Clinical trial update describing a randomized, double-blind study of the Neuromonics Tinnitus Treatment Program for tinnitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: United States Army Aeromedical Research Laboratory | Conditions: Tinnitus | NA | Status: UNKNOWN